Observational studyCancer medicine2024

Real-World Prevalence, Treatment Patterns, and Outcomes for Patients With HER2 (ERBB2)-Mutant Metastatic Non-Small Cell Lung Cancer, From a US-Based Clinico-Genomic Database.

Sarah Waliany et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.